Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA-Reference-Cited by-同舟云学术

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA

Published:2019-05-01 Issue:5 Volume:26 Page:432-441
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kitagawa Kazuo¹,Hosomi Naohisa²,Nagai Yoji³,Kagimura Tatsuo⁴,Ohtsuki Toshiho⁵,Maruyama Hirofumi²,Origasa Hideki⁶,Minematsu Kazuo⁷,Uchiyama Shinichiro⁸,Nakamura Masakazu⁷,Matsumoto Masayasu²⁹,

Affiliation:

1. Department of Neurology, Tokyo Women’s Medical University

2. Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences

3. Clinical and Translational Research Center, Kobe University Hospital

4. Foundation for Biomedical Research and Innovation at Kobe, Translational Research Center for Medical Innovation

5. Stroke Center, Kindai University Hospital

6. Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences

7. National Cerebral and Cardiovascular Center

8. Clinical Research Center, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Medical Center

9. Sakai City Medical Center, Sakai City Hospital Organization

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/26/5/26_45989/_pdf

Reference18 articles.

1. 1) Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2014; 129 (25 Suppl 2): S1-45

2. 2) Ridker PM. From C-reactive protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circ Res, 2016; 118: 145-156

3. 3) Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA, 2001; 286: 64-70

4. 4) Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359: 2195-2207

5. 5) Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS Collaborators. A Multicenter, Randomized, Open-label, Parallel-group Study. EBioMedicine, 2015; 2: 1071-1078

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database;European Stroke Journal;2024-09-10

2. IL-6 and stroke recurrence in ischemic stroke;Biomarkers in Medicine;2024-09-04

3. Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke;2024-05-22

4. Using a k-means clustering to identify novel phenotypes of acute ischemic stroke and development of its Clinlabomics models;Frontiers in Neurology;2024-03-27

5. Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins;Frontiers in Cardiovascular Medicine;2024-01-15